DKSC (Dakshidin) Stock Based Compensation: $0.00 Mil (TTM As of Sep. 2023)


What is Dakshidin Stock Based Compensation?

Dakshidin DKSC +33.33% Stock Based Compensation is $0.00 Mil as of Sep. 2023.

Dakshidin's Stock Based Compensation for the three months ended in Sep. 2023 was $0.00 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Sep. 2023 was $0.00 Mil.

Dakshidin Stock Based Compensation Related Terms

Dakshidin Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Dakshidin's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dakshidin Stock Based Compensation Chart

Dakshidin Annual Data
Trend
Stock Based Compensation

Dakshidin Quarterly Data
Mar19 Mar20 Sep22 Sep23
Stock Based Compensation 0.00 0.00 0.00 0.00

Dakshidin Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

What does a Stock Based Compensation of $0.00 Mil mean?
Dakshidin (DKSC) has a Stock Based Compensation of $0.00 Mil as of Sep. 2023. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Dakshidin and its competitors.
Is Dakshidin's Stock Based Compensation too high?
Dakshidin's current Stock Based Compensation is $0.00 Mil.
How does Dakshidin's Stock Based Compensation compare to ECEZ and AFBG?
Dakshidin's Stock Based Compensation of $0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Drug Manufacturers company?
A good Stock Based Compensation depends on the Drug Manufacturers industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Dakshidin and its competitors. Dakshidin's current Stock Based Compensation is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dakshidin stock overvalued right now?
Dakshidin (DKSC) has a current Stock Based Compensation of $0.00 Mil. The current Stock Based Compensation is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Dakshidin (DKSC), the current Stock Based Compensation is $0.00 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Dakshidin Business Description

Address 508 Locust Street, Lockport, NY, USA, 14094
Dakshidin Corp is a Cannabis-based medical product company. The company operates through its online e-commerce store laughingfrogs.com. The company is composed of four synergistic entities: Laughing Frogs, an online sales portal for the company's CBD products; Laughing Frogs Nutraceutical the online sales portal for all non-CBD hemp oil products and its proprietary nutraceutical products, company's new PPE division and Runnymede Farms, a company that is focused on the cultivation of specifically grown Hemp plants. through its growing operations and Joint Ventures with established growers.